Data Suggests Improved Disease Control With FASLODEXTM 500mg Compared With Anastrozol

		HER2 Support Group Forums > Breast Cancer Newsfeed
Data Suggests Improved Disease Control With FASLODEXTM 500mg Compared With Anastrozol

12-10-2010, 08:30 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,957	Data Suggests Improved Disease Control With FASLODEXTM 500mg Compared With Anastrozol New data presented at the CTRC-AACR 33rd Annual San Antonio Breast Cancer Symposium, USA, suggest fulvestrant 500mg offers improved disease control compared with the aromatase inhibitor, anastrozole, when used as a first-line treatment* for hormone receptor positive breast cancer... More...

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 09:19 PM.